Myrexis (MYRX) Announces Findings of Tumor Reduction from MPC-9528
Tweet Send to a Friend
Myrexis, Inc. (Nasdaq: MYRX) announces the presentation of key findings from MPC-9528 preclinical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
